10-Q
Quarterly Report
ALTO INGREDIENTS, INC.
ALTO
NASDAQ
CIK: 778164
File #: 000-21467
Balance Sheet
50 line items · 2 periods
XBRL
| Item | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|
Current Assets: | ||
Cash and cash equivalents | 29,310,000 | 30,014,000 |
Restricted cash | 12,762,000 | 15,466,000 |
Cash collateral balance | 12,762,000 | 15,466,000 |
Accounts receivable (net of allowance for credit losses of $58 and $85, respectively) | 58,081,000 | 58,729,000 |
Inventories | 42,610,000 | 52,611,000 |
Derivative instruments | 52,000 | 2,412,000 |
Commodity Contract | 52,000 | 2,412,000 |
Derivative Financial Instruments, Assets | 52,000 | 2,412,000 |
Derivative Financial Instruments, Assets - Fair Value, Inputs, Level 1 | 52,000 | 2,412,000 |
Other current assets | 8,028,000 | 9,538,000 |
Total current assets | 150,843,000 | 168,770,000 |
Property and equipment, net | 248,901,000 | 248,748,000 |
Other Assets: | ||
Right of use operating lease assets, net | 21,506,000 | 22,597,000 |
Intangible assets, net | 8,351,000 | 8,498,000 |
Other assets | 5,034,000 | 5,628,000 |
Total other assets | 34,891,000 | 36,723,000 |
Total Assets | 434,635,000 | 454,241,000 |
Pekin Campus production | 250,773,000 | 251,048,000 |
Marketing and distribution | 92,747,000 | 101,196,000 |
Other production | 52,755,000 | 57,533,000 |
Corporate and other[ Member] | 38,360,000 | 44,464,000 |
Current Liabilities: | ||
Accounts payable | 18,508,000 | 20,752,000 |
Accrued liabilities | 18,166,000 | 20,205,000 |
Current portion – operating leases | 4,486,000 | 4,333,000 |
Derivative instruments | 8,299,000 | 13,849,000 |
Commodity Contract | 8,299,000 | 13,849,000 |
Derivative Financial Instruments, Liabilities | (8,299,000) | 13,849,000 |
Derivative Financial Instruments, Liabilities - Fair Value, Inputs, Level 1 | (8,299,000) | 13,849,000 |
Other current liabilities | 5,595,000 | 6,149,000 |
Total current liabilities | 55,054,000 | 65,288,000 |
Long-term debt | 84,069,000 | 82,097,000 |
Operating leases, net of current portion | 17,895,000 | 19,029,000 |
Other liabilities | 8,958,000 | 8,270,000 |
Total Liabilities | 165,976,000 | 174,684,000 |
Stockholders’ Equity: | ||
Preferred stock, value | 1,000 | 1,000 |
Common stock, value | 77,000 | 76,000 |
Additional paid-in capital | 1,042,053,000 | 1,040,912,000 |
Accumulated other comprehensive income | 2,481,000 | 2,481,000 |
Accumulated deficit | (775,953,000) | (763,913,000) |
Total stockholders’ equity | 268,659,000 | 279,557,000 |
Preferred Stock | 1,000 | 1,000 |
Common Stock | 77,000 | 76,000 |
Additional Paid-In Capital | 1,042,053,000 | 1,040,912,000 |
Accumulated Deficit | (775,953,000) | (763,913,000) |
Accum. Other Comprehensive Income | 2,481,000 | 2,481,000 |
Total Liabilities and Stockholders’ Equity | 434,635,000 | 454,241,000 |